Market Research Blog – Page 753 – New Product Development

Global Refurbished Dental Equipment Market Poised to Reach USD 1.8 Billion by 2033 at a 8.7% of CAGR

Refurbished Dental Equipment Industry — Refurbished Dental Equipment Market

The global refurbished dental equipment market, which was valued at USD 741.9 million in 2022. The market is expected to increase by 7.2% year-over-year in 2023, reaching USD 797.3 million. Over the forecast period from 2023 to 2033, demand for refurbished dental equipment is projected to rise at a CAGR of 8.7%, ultimately achieving a market value of USD 1.8 billion by 2033. This growth underscores a strong preference among dental practices for affordable, high-quality equipment solutions.

Key Growth Drivers

Several factors are propelling the expansion of the refurbished dental equipment market:

Increasing Adoption of Cost-Effective Dental Solutions: With dental practices seeking to balance cost and quality, refurbished equipment offers a budget-friendly alternative without compromising on performance.
Rising Demand for Dental Services Globally: As dental care services grow worldwide, more practices are turning to refurbished equipment to meet patient needs while managing expenses.
Environmental Benefits and Sustainability: Refurbished dental equipment supports sustainability efforts by reducing waste, which appeals to environmentally conscious healthcare providers.

Refurbished dental equipment refers to used dental equipment that has been restored, repaired, and tested to ensure it functions properly and meets industry standards before being resold. These pieces of equipment could include dental chairs, dental lasers, dental units, dental X-ray machines, sterilizers & other dental instruments.

The refurbishment process typically involves thorough cleaning, replacement or repair of any damaged or worn-out components, and calibration or adjustment to ensure proper functionality. The equipment is inspected to ensure it meets safety and performance standards, and any necessary upgrades or modifications may be made.

High costing Dental equipment such as dental 3D imaging systems, intraoral cameras, dental lasers, surgical microscope, etc., are available from a range of manufacturers and may vary in design and specifications. Equipment is often available at a lower price compared to buying new equipment. This allows dental practices to save money, especially if they have budget constraints or are starting up.

Competitive Landscape

Leading companies are focusing on increasing their product portfolios in order to improve their competitive position in the marketplace and increase their reach in emerging regions. The key techniques used by manufacturers to get a competitive edge in the market consist of pricing strategies, marketing approaches, advances in technology, compliance with regulations, and acquisition and distribution agreements with other businesses to expand their business.

For instance:

In May 2022, Al-Khayyat Investments Group (AKI) – Alphamed, a group established in the UAE, and A-dec were pleased to announce their new dealer collaboration for distribution & exemplary logistical provision.
Henry Schein, Inc. announced in April 2023 that it had purchased a controlling interest in Biotech Dental S.A.S., a quickly growing French business that sells dental implants, transparent aligners, including innovative digital dental software.

Key Companies Profiled

American Dental Refurbishment; Atlas Resell Management; A & K Dental Equipment; Capital Dental Equipment; Collin’s Dental Equipment, Inc.; Independent Dental Inc.; Pre-Owned Dental Inc.; SPS Dental; Renew Digital LLC; DCI Dental Equipment

A Comprehensive Full Report

Key Segments Covered in Refurbished Dental Equipment Industry Research

By Product:

Specialized Dental Equipment
- Intraoral Cameras
- Chairside CAD/CAM Systems
- 3D Imaging Systems
- Surgical Microscopes
- Dental Lasers
- Endodontic Equipment
- Cone Beam Computed Tomography (CBCT) Systems
- Others
Essential Dental Equipment
- Dental Patient Chairs
- Delivery Systems
- Dental Operatory Lights
- X-ray Imaging Equipment
- Sterilization Equipment
- Handpieces
- Utility Equipment
- Others

By End User:

Hospitals
Independent Dental Clinics
Group Dental Practices
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Digital Psychotherapeutics Market to Surpass USD 12.2 Billion by 2033 at a 27.6% CAGR

The global digital psychotherapeutics market is projected to reach a valuation of USD 1.06 billion in 2023 and is expected to experience robust growth over the next decade. According to Future Market Insights, demand for digital psychotherapeutic solutions is forecasted to accelerate at an impressive CAGR of 27.6%, with total market value anticipated to exceed USD 12.2 billion by 2033. This remarkable growth trajectory highlights the expanding role of digital tools in mental health care and the increasing adoption of technology-driven therapies.

Key Factors Fueling Market Growth

The expansion of the digital psychotherapeutics market is being driven by several critical factors:

Rising Demand for Accessible Mental Health Care: Digital psychotherapeutics offer greater accessibility for individuals seeking mental health support, addressing the shortage of mental health professionals and reducing barriers to care.
Advancements in AI and Digital Therapy Platforms: Ongoing innovations in AI and machine learning are enabling more personalized and effective psychotherapeutic interventions, increasing the appeal of digital therapies.
Increasing Awareness and Acceptance of Mental Health Support: With growing awareness and reduced stigma around mental health, more individuals are turning to digital platforms for therapy and support, fueling market demand.

Future Market Insights’ analysis reflects a bright future for the digital psychotherapeutics market, as technology continues to reshape mental health care delivery. With strong growth expected, digital psychotherapeutics are well-positioned to become a cornerstone of mental health treatment globally.

Digital psychotherapeutics refers to mental health aid delivery through electronic devices that involve the use of internet. It can also be called e-therapy, e-counseling, or online counseling.

Digital psychotherapeutics involves the treatment of behavioral, emotional, personality, and psychiatric disorders through verbal and nonverbal communication and interventions. Digital and internet-based health technologies are experiencing high demand in this field over recent years. Research suggests this has spurred change in patient behavior and positively affected prognosis.

Digital psychotherapeutics can be used as a standalone treatment or in conjunction with other conventional treatments such as in-person or pharmacological therapy. Various studies have revealed that digital psychotherapy, especially cognitive behavioral therapy, can be as effective as face-to-face psychotherapy.

Mental health problems not only affect a person emotionally but physically as well. Various treatment options such as drugs and non-drug treatment are available for these mental disorders.

Psychiatric medications are associated with several side effects including nausea, headache, dizziness, sexual problems, nausea, constipation, etc. As a result, people are gradually shifting their preference towards psychotherapy, including digital psychotherapeutics.

Digital psychotherapeutics offers various benefits including low cost and easy accessibility. Rising awareness about the benefits associated with digital psychotherapeutics is expected to boost the market.

Opportunities in the Digital Psychotherapeutics Industry:

Incorporation of advanced technologies for best practices related to design, clinical evaluation, usability, and data security will create new opportunities.
Rising demand for innovative mental health solutions with insights, and heavy investment in employee mental health is likely to boost the market.
Personalized mental healthcare through expert systems and rise in critical behavioral health support to aid market growth.
Growing popularity of computer-assisted cognitive-behavior therapy will create lucrative opportunities for digital psychotherapeutics providers.

Latest Trends in the Digital Psychotherapeutics Market:

Growing trend in digital healthcare solutions enabling patients to select their own mental health professional will boost the market.
Significant increase in venture capital investments is expected to boost the digital psychotherapeutics industry.
Changing medical protocols, as well as the need to reduce healthcare costs will increase digital therapeutics investments.

Get Full Report Now

Key Companies Profiled

SwissDTx; Starling Minds; Woebot Health; Talkspace; Pear Therapeutics; Ginger; Meru; Spring Care, Inc.; AbleTo, Inc.; Novartis; SilverCloud Health; FlyingPepper; BetterHelp

Global Digital Psychotherapeutics Market Segmentation

By Solution:

Monotherapy
Combination Therapy

By Application:

Prevention
Management
Treatment

By Business Model:

Direct-to-Patients/Consumers
Business-to-Business (B2B)

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Mastectomy Reconstruction Implants Market Expected to Reach USD 4.69 Billion by 2033 at a 8.4% of CAGR

Global Mastectomy Reconstruction Implants Industry — Global Mastectomy Reconstruction Implants Market

The global mastectomy reconstruction implants market, valued at USD 1.95 billion in 2022 and projected to reach USD 4.69 billion by 2033. This significant expansion underscores the increasing adoption of reconstruction implants following mastectomies, driven by rising awareness, advancements in implant technology, and enhanced access to breast reconstruction options.

Key Market Drivers

Several factors are contributing to the steady growth of the mastectomy reconstruction implants market:

Growing Awareness and Acceptance of Post-Mastectomy Reconstruction: Rising awareness around reconstructive options post-mastectomy is empowering patients, contributing to the market’s expansion.
Technological Advancements in Implant Materials and Design: Innovations in implant technology, including enhanced biocompatibility and natural appearance, are driving increased adoption.
Increased Access to Reconstructive Procedures Globally: Greater availability of skilled professionals and healthcare facilities providing mastectomy reconstruction is making these options accessible to a broader population.

As the demand for post-mastectomy reconstruction solutions continues to grow, the mastectomy reconstruction implants market is set for strong expansion. FMI’s insights signal a promising outlook, with ongoing advancements in technology and patient empowerment leading to sustained market growth.

Mastectomy reconstruction implants are breast implants that are used to reconstruct the breast tissue after a mastectomy, which is a surgical procedure in which one or both breasts are removed due to cancer or other medical conditions. The implants are typically made of silicone or saline and are placed under the chest muscle or breast tissue to create a natural-looking breast shape.

Overall, the increasing incidence of breast cancer, the growing demand for cosmetic surgeries, and the availability of technologically advanced breast implants, will boost the market in the coming years.

For instance, In 12 November 2019, BellaSeno and Evonik collaborated to bring an advanced 3D-printed breast implant technology to market. This technology designed to improve quality of life for patients after breast reconstruction and augmentation.

Competitive Landscape

Key players in the market are focused on increase their product portfolio to strengthen their position in the market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and approvals of the products to expand their business.

For instance:

In 2020, GC Aesthetics plc received approval from the FDA for its NaturaCel breast implants. These implants are designed to provide a natural look and feel for women undergoing breast reconstruction surgery.
In 2020, Allergan, Inc. received approval for Natrelle Inspira SoftTouch breast implants from the USA Food and Drug Administration (FDA). These implants are designed to provide a softer feel and a more natural look for women who are undergoing breast reconstruction surgery.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the mastectomy reconstruction implants market space, which are available in the full report

Key Companies Profiled

Mentor Worldwide LLC (Johnson & Johnson Services, Inc.); AbbVie Inc. (Allergan PLC); Hans Biomed Co., Ltd; Galderma SA; GC Aesthetics; POLYTECH Health & Aesthetics GmbH; Sintera Inc; PMT Corporation; Ideal Implant Inc; Groupe Sebbin SAS; Hologic, Inc; Guangzhou Wanhe Plastic Materials Co., Ltd; Establishment Labs S.A; RTI Surgical Holdings Inc.; Nagor Limited

Grab Your Complete Report Instantly

Key Segments Covered in Mastectomy Reconstruction Implant Industry Research

By Product:

Two-Stage Implant Reconstruction (matrix (ADM))
- Prepectoral Breast Reconstruction Surgery
- Sub-pectoral Breast Reconstruction Surgery
Direct-to-Implant Reconstruction

By End User:

Hospitals
Cosmetology Clinics
Ambulatory Surgical Centers
Medical Spas

By Region:

North America
Latin America
East Asia
South Asia & Pacific
Western Europe
Eastern Europe
Central Asia
Russia & Belarus
Balkan & Baltic Countries
Middle East and Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Esophageal Implant Market Poised for Strong Growth, Expected to Surpass USD 280 Million by 2033 at a 6.7% of CAGR

The global esophageal implant market is set for substantial growth, with its valuation projected to reach USD 147 million in 2023. Over the next decade, the market is anticipated to expand at a CAGR of 6.7%, ultimately exceeding USD 280.2 million by 2033. This promising growth trajectory is attributed to increasing demand for advanced solutions in the treatment of esophageal disorders and the continuous innovation within the implant sector.

Key Growth Drivers

The expansion of the esophageal implant market is being driven by several crucial factors:

Rising Prevalence of Esophageal Disorders: An increase in esophageal conditions such as strictures and cancers has created a rising need for effective therapeutic options, including esophageal implants.
Advancements in Implant Technology: New technologies are enhancing the safety, effectiveness, and biocompatibility of esophageal implants, making them a more viable option for patients and healthcare providers.
Increased Adoption of Minimally Invasive Procedures: Minimally invasive implants are becoming a preferred choice for patients seeking reduced recovery times and less post-operative discomfort.

As the demand for innovative esophageal treatment solutions grows, the market for esophageal implants is well-positioned for sustained growth. Future Market Insights’ analysis indicates a bright future for the industry, driven by advancements in technology and a global rise in esophageal health concerns.

The market growth is being propelled due to the rising need for surgical resection of the esophagus as a result of cancer, trauma, or birth defects.

As per the Centers for Disease Control and Prevention, around one child suffers from esophageal atresia in every 4,100 children born in the United States. This birth condition can occur on its own, although it is more commonly associated with other birth problems. Such escalating faults are important drivers fueling market expansion.

Esophageal implants have emerged as the most effective treatment for a variety of illnesses, including GERD and esophageal strictures. As a result of the increasing efficacy of these implants in therapies, the demand for esophageal implants is increasing.

Rising patient inclination towards minimally invasive procedures is another key factor that is expected to fuel esophageal implant demand globally. Subsequently, growing popularity of biodegradable stents and hybrid implants is likely to support market expansion.

Leading esophageal implant manufacturers are concentrating on developing new innovative solutions with several advantages. For instance, to treat esophageal atresia and other esophageal disorders, Biostage is developing its Cellspan esophageal implant.

Key Drivers Propelling the Demand for Esophageal Implants

Despite surgical procedures, esophageal implants play a critical role in symptom reduction for chronic esophageal diseases like GERD, driving demand.
Rapid increase in the cases of esophageal cancer is likely to create lucrative opportunities for esophageal implant manufacturers, with especially high demand for esophageal stents.
Growing preference for minimally invasive treatment approaches for esophagus-related problems will fuel esophageal implant sales.
Rising usage of self-expandable metallic stents in the treatment of benign & malignant disorders is expected to boost sales.

How Key Players Stay Competitive in the Esophageal Implant Industry?

The esophageal implant industry is highly competitive due to large presence of regional and local players. In such a scenario, companies must adopt effective strategies to stay ahead of the competition.

Key Strategies Adopted by the Players:

Product Innovation

Companies are investing rigorously in research and development to introduce new products with enhanced features. Product innovation enables manufacturers to differentiate themselves from their competitors and meet the evolving needs of customers.

Strategic Partnerships and Collaborations

Key players in the industry often form strategic alliances, collaborations, and partnerships with other companies to leverage their strengths and expand their reach in the market.

Expansion into Emerging Markets

The esophageal implant industry is witnessing significant growth in emerging markets such as China and India. Key esophageal implant manufacturers are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks.

Mergers and Acquisitions

Key esophageal implant companies are also adopting mergers and acquisitions to strengthen their market position, expand their portfolio, and gain access to new markets.

Key Players in the Esophageal Implant Industry:

Boston Scientific
Medtronic
Cook Medical
Taewoong Medical
Micro-Tech (Nanjing) Co., Ltd.
Ella-CS
M.I. Tech
Merit Medical
Xlumena Inc.
Olympus Corporation
Johnson & Johnson
Apollo Endosurgery, Inc.
EndoStim
NDO Surgical, Inc
Mederi Therapeutics
Becton Dickenson & Company
Baxter International (Synovis Surgical Innovations)

Key Developments in the Esophageal Implant Industry:

Boston Scientific Corporation, Inc., will acquire Apollo Endosurgery, Inc., for a cash price of $10 per share, or around $615 million as per the statement released by Boston Scientific on Nov 2022.
In February 2023, Olympus disclosed its plan to acquire Korea based Taewoong Medical (manufacturer of stents) at $370 million.
In June 2022, a definitive agreement was signed between Boston Scientific Corporation and Synergy Innovation Co., Ltd., under which the company will buy a majority stake (roughly 64 percent) in M.I.Tech Co., Ltd., a Korean company involved in production and supply of medical devices for endoscopic and urologic procedures.

Grab Your Complete Report Instantly

Esophageal Implant Market Segmentation

By Product:

Esophageal Stents
- Self-Expandable Metal Stents (SEMS)
- Polymer Stents
- Biodegradable Stents
- Hybrid Stents
Magnetic Sphincter Augmentation (MSA) Devices
Injectable Bulking Agents
Artificial Esophageal Valves
- Endoscopic Esophageal Valves
- Prosthetic Esophageal Valves

By Application:

Gastroesophageal Reflux Disease (GERD)
Esophageal Strictures
Esophageal Fistulas
Esophageal Defects
Weakened Esophageal Sphincters

By End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Academic & Research Institutions
Weakened Esophageal Sphincters

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Image Guided Systems Market Set to Reach USD 17.41 Billion by 2033 at a 8.4% of CAGR

The global image guided systems market, valued at USD 7.23 billion in 2022, is expected to experience significant growth over the next decade, reaching USD 17.41 billion by 2033. This robust expansion is largely fueled by the devices segment, which currently holds more than 75% of the market share within the product category. This segment is forecasted to grow at a CAGR of approximately 8.2% from 2023 to 2033, underscoring its leading position in the market.

Key Growth Drivers

Several factors are propelling the image guided systems market forward:

Rising Demand for Minimally Invasive Procedures: Image guided systems play a crucial role in enhancing precision in minimally invasive surgeries, which are increasingly favored for reduced recovery times and improved outcomes.
Technological Advancements in Imaging and Navigation: Continuous advancements in imaging and guidance technologies are improving the accuracy and effectiveness of these systems, driving adoption across medical facilities.
Expanding Applications in Complex Surgeries: With growing applications across neurosurgery, orthopedics, and oncology, image guided systems are becoming essential in complex surgical procedures.

The devices segment’s dominance reflects the high demand for reliable, advanced image guidance solutions in healthcare. Future Market Insights’ analysis signals a promising outlook for the image guided systems market, with steady growth anticipated as technology advances and healthcare providers seek cutting-edge surgical tools.

Image guided surgery (IGS) refers to the application of a real-time correlation of the surgical field to a preoperative imaging data collection that reflects the precise placement of a chosen surgical instrument to the adjacent anatomic structures. Since the development of the endoscopic approach in the middle of the 1980s, image guided surgery has been one of the most important developments in endoscopic approach surgery.

Conventional surgical techniques take longer, are less precise, and include a risk of injury to neighboring nonsurgical areas. As a result, there is a rising need for surgical methods that are more accurate and quick. The benefits of image guided surgery devices include reduced damage, quicker healing of surgical wounds, and higher levels of accuracy.

Competitive Landscape

Key image guided system market companies are investing substantial resources in new product innovation, providing unique equipment to treat patients, and providing life-sustaining treatment. Some major businesses are acquiring other companies in order to strengthen their global market positions, while others are focusing on product launches.

For instance:

Philips launched EchoNavigator 4.0, a new release of their image-guided treatment system for treating structural heart disease, internationally in May 2022.
GE Healthcare launched the newest iteration of the angiography system which is robotic-driven for image-guided therapy and named it Allia IGS 7 angiography system, in December 2020.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the image guided systems market space, which are available in the full report

Key Companies Profiled

Siemens Healthineers; Analogic Corporation; GE Healthcare; Koninklijke Philips N.V.; Stryker Corporation; Carestream Health; Hitachi Medical Corporation; Hologic; United Imaging Technologies Inc.; BrainLab AG; Karl Storz Gmbh & Co. Kg; Smith & Nephew Plc; Esaote SpA; Zimmer Biomet; Varian Medical Systems, Inc.; Medtronic Plc.; EndoMed Systems; Maxer Endoscopy; Blazejewski MEDI-TECH GmbH; Olympus Corporation; FUJIFILM Holdings Corporation; Shenyang Shenda Endoscope Co., Ltd.; Shimadzu Corporation; Shenzhen Anke High-tech Co., Ltd.

Get the Comprehensive Full Report Now

Key Segments Covered in Image Guided Systems Industry Research

By Product:

Devices
- Computed Tomography (CT) Scanners
- Ultrasound Systems
- Magnetic Resonance Imaging (MRI)
- Endoscopes
- X-ray Fluoroscopy
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
Softwares

By Application:

Cardiac Surgery
Neurosurgery
Orthopedic Surgery
Gastroenterology
Urology
Oncology Surgery
Others (ENT, Dental, Pulmonary surgery)

By End User:

Hospitals
Ambulatory Surgical Centers
Clinics
Research & Academic Institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Synchrotron Instrumentation Market Anticipated to Reach USD 1.80 Billion by 2033 at a 5.6% of CAGR

The global synchrotron instrumentation market over the coming decade. Valued at USD 1.00 billion in 2022, the market is expected to experience a year-over-year (Y-o-Y) growth of 4.8% in 2023, bringing it to USD 1.05 billion. From 2023 to 2033, the market is forecasted to grow at a CAGR of 5.6%, ultimately reaching USD 1.80 billion by 2033.

Key Drivers of Market Growth

The synchrotron instrumentation market expansion is attributed to several important factors:

Rising Investment in Advanced Research Facilities: With synchrotrons used in various applications from material science to biology, increased funding and investment in state-of-the-art research infrastructure are key growth drivers.
Technological Advancements in Instrumentation: Improvements in beamline technology, imaging systems, and analytical instruments are enhancing the precision and scope of synchrotron applications, fueling demand.
Expanding Applications Across Industries: From pharmaceuticals to nanotechnology, the market is benefiting from the broader adoption of synchrotron-based analysis in diverse industries.

FMI’s research suggests a promising outlook for the synchrotron instrumentation market, as the ongoing demand for advanced analytical capabilities continues to grow. The market is well-positioned for steady growth, supported by technological innovation and a widening scope of applications.

Synchrotron instrumentation refers to the specialized equipment and techniques used in synchrotron facilities for scientific research. Synchrotrons are large particle accelerators that produce highly intense and focused beams of electromagnetic radiation, ranging from X-rays to infrared light. These facilities are utilized by scientists from various disciplines, including physics, chemistry, biology, materials science, and medicine, to conduct cutting-edge research.

Beamlines are the primary experimental stations where researchers conduct their experiments. A synchrotron facility typically has multiple beamlines, each dedicated to a specific research area or technique. Beamlines consist of a series of optical elements, such as mirrors, lenses, monochromators, and detectors, which manipulate and measure the synchrotron radiation.

X-ray spectroscopy techniques provide valuable insights into the electronic and chemical properties of materials. Instruments like X-ray absorption spectroscopy (XAS), X-ray emission spectroscopy (XES), and X-ray photoelectron spectroscopy (XPS) are employed to analyze the energy levels and transitions of electrons in a sample. This helps researchers understand the chemical composition, oxidation states, and bonding within materials.

Competitive Landscape

The market’s major companies are concentrating on diversifying their product offerings to boost their market share in synchrotron instrumentation and to broaden their presence in developing economies. Market strategies, technological developments, conferences, acquisitions, and distribution agreements with other businesses are the main tactics used by manufacturers to obtain a competitive edge in the market.

For instance:

In March 2019, AgfaLabs acquired a new Agilent Cary 620 ‘synchrotron-in-a-microscope’ FTIR imaging system.
In June 2018, Rigaku Innovative Technologies (RIT) announced its participation in the 13th International Conference on Synchrotron Radiation Instrumentation.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the synchrotron instrumentation market space, which are available in the full report

Key Companies Profiled

ZEISS; SYNCHROTRON RESEARCH INC.; FMB Oxford Ltd.; Rigaku Corporation; Quantum Design Inc.; TOP-UNISTAR (HK) SCIENCE & TECHNOLOGY CO., LTD.; Shimadzu Corporation; Proto Manufacturing; Agilent Technologies; HUBER Diffraktionstechnik GmbH & Co. KG; DECTRIS AG; Avaco; Rayonix, L.L.C.; AVS. Added Value Solutions; Xenocs; Malvern Panalytical Ltd; Alemnis; JJ X-Ray A/S; Thermofisher Scientific; Edwards Vacuum; G&H Group

Get the Comprehensive Full Report Now

Key Segments Covered in Synchrotron Instrumentation Industry Research

By Product:

Optical Devices
- Other Beam Line Components
  - Slits
  - Shutters
  - Florescent Screens
  - Windows
  - Beam deflectors
- Mirrors
- Objective Lenses
- Detectors
- Diagnostics
- Monochromators
- Vacuum Systems
Instruments
- Diffraction Gratings systems/ diffractometer
- X-Ray Tomography
- Small-angle X-ray scattering (SAXS)
- Large Area Rapid Imaging Analytical tool (LARIAT)
- sub-micron CT/XRM
- X-Ray absorption spectroscopy (XAS)
- X-Ray fluorescence (XRF)
- Spectrometers
- FTIR
- Nano-mechanical test instrumentation
- Cryo-Electron Microscopy

By Application:

Nanoparticles and colloids
Drug Discovery and Formulations
Polymer Research
Food Sciences
Medical research
Toxicology
Material Research
Semiconductors research
Others

By End Use Industry:

Oil and Gas
Food Industry
Cosmetic & Consumer care
Renewable Energy
Medical Industry
Pharmaceutical Industry
Environmental Sciences
Agriculture
Electronics Industry

By Region:

North America
Europe
Asia Pacific
Rest of the World

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Robotic Lung Biopsy Market Set to Surge, Expected to Exceed USD 1,023.05 Million by 2033 at a 9.6% of CAGR

The global robotic lung biopsy market is on track for remarkable growth, projected to reach USD 408 million in 2023 and expand at a robust 9.6% CAGR through 2033. By the end of this forecast period, the total market valuation is expected to surpass USD 1.023 billion, driven by advancements in robotic-assisted diagnostic tools and the rising demand for minimally invasive procedures.

Key Factors Driving Market Growth

Several trends are fueling the rapid expansion of the robotic lung biopsy market:

Increasing Demand for Minimally Invasive Procedures: Robotic lung biopsy offers a less invasive, precise alternative to traditional lung biopsy methods, leading to faster recovery and reduced patient discomfort.
Technological Advancements in Robotic Diagnostics: Improvements in robotic systems and imaging technology are enhancing procedural accuracy and expanding the range of lung lesions that can be biopsied.
Growing Incidence of Lung Cancer and Respiratory Disorders: As the global prevalence of lung cancer and other pulmonary conditions rises, demand for early and accurate diagnostic tools like robotic lung biopsy systems is increasing.

Future Market Insights’ analysis highlights the robust growth potential within the robotic lung biopsy market, which is anticipated to transform diagnostic capabilities in pulmonary care. With the projected surge in market value, the industry is poised for continued innovation, offering substantial benefits to healthcare providers and patients alike.

2018 to 2022 Robotic Lung Biopsy Sales Outlook Compared to Demand Forecast from 2023 to 2033

From 2018 to 2022, the global robotic lung biopsy market experienced a CAGR of 11.2% CAGR. Total market value at the end of 2022 reached around US$ 379.7 million.

From 2018 to 2022, the global robotic lung biopsy industry witnessed steady growth due to the rising demand for lung cancer control systems. The market for robotic lung biopsies was just getting started at the time, and adoption rates were quite low.

Due to their high price, limited availability, and the perceived risk associated with robotic surgery, many healthcare professionals were reluctant to invest in these systems.

As per estimates from Intuitive Surgical in 2022, a total of 321 Ion end luminal systems were installed globally.

Looking ahead, the global robotic lung biopsy industry is expected to progress at a CAGR of 9.6% from 2023 to 2033. By the end of 2033, the market size is expected to reach US$ 1,023.05 million.

Rising cases of lung cancer and shift towards minimally invasive procedures are key factors that are expected to drive the global market forward.

Key Companies Profiled

Ethicon, Inc. (Johnson & Johnson); Intuitive Surgical.

Get Complete Full Report

Robotic Lung Biopsy Market Segmentation

By Product and Services:

System
Instruments and Accessories
Service

By Navigation Technology:

Electromagnetic and Optical Navigation
Fiber Optic RealShape Navigation

By End User:

Hospitals
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

FMI Analysts Predict FWA Subscriptions to Surpass 14 Billion in Revenue by 2033: Get a Gist of the Industry

The revenue from FWA subscriptions is anticipated to increase from its projected value of US$ 180.19 Million in 2023 to US$ 14,422.74 Million by 2033, rising at a CAGR of 55% during the forecast period.

The revenue from FWA subscriptions is rising as it can reduce the large upfront costs and time necessary to get permissions, dig trenches, lay last-mile fiber, and deploy technician-installed equipment at residences and businesses since it is wireless. Operators usually use their present mobile wireless networks and fiber backhaul equipment to construct FWA, which further reduces expenses. Additionally, operators now have cutting-edge methods and resources available to them (such as microcells and site densification) that will enable them to manage circumstances where demand exceeds supply.

The increase in FWA subscriptions has consequences for several significant market players. Most obviously, network operators have the opportunity to use FWA as an extra revenue stream. Even though FWA subscriptions are now less profitable than mobile, the majority of wireless networks-aside from those in the densest urban areas-are underutilized. Therefore, introducing FWA service to this underutilized capacity may boost earnings.

Cable providers should also take into account the growing competition from mobile network operators, who are bundling 5G FWA with mobile subscriptions to attract new customers and foster stickiness. Although 5G FWA does not now pose an existential threat to cable, when available, conventional connections almost always provide a more dependable connection than wireless options. This may alter, though, if its economics and ease of use continue to improve.

Key Takeaways from the FWA Subscription

The FWA subscription revenues grew at a CAGR of 50% from US$ 60.0 Million in 2020 to US$ 135.0 Million in 2021, according to Future Market Insights.
The residential application category is expected to see the most adoption due to the growing broadband connectivity in households and individuals.
In the US, it is projected that FWA subscription revenue is likely to be US$ 932.3 Million in 2023.
During the projection period, FWA Subscriptions in Germany are expected to increase across Europe at a pace of around 63.8% CAGR.
The regional market of Japan is noteworthy, with FWA subscriber growth rates of 83.6% from 2023 to 2033.
It is estimated that China, the second-largest economy in the world, would expand at a CAGR of 88.7% between 2023 and 2033 to reach a projected market size of US$40.2 Billion.

Get a sample PDF of the report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15862

Who is Winning?

Due to the number of significant solution providers all over the world that are persistently attempting to get more market penetration. The businesses are forming strategic alliances and collaborations, raising money to launch new products, and improving on current ones to gain more market exposure.

The feasibility of FWA subscriptions from a business standpoint is growing significantly. It may be the most practical and economical option for bringing the internet to both impoverished regions and competitive markets due to its superior cost and quality profile, in addition to its growing popularity as a substitute for wired connections. As a result, FWA subscriptions could potentially contribute significantly to boosting internet accessibility while giving telecom firms new revenue, development, and innovation opportunities-possibly creating a win-win scenario for all parties involved.

One of the front-runners in the competition is Ericsson, which has a market value of over $25 billion and is leading investments in the development of 5G technology. Major mobile operators from across the world, including Verizon and AT&T in the United States, China Mobile (CHL) in China, and SK Telecom Company Ltd. in South Korea, are all actively taking part in research studies and field testing.
Additionally, businesses like Nokia and Qualcomm, Inc., with market capitalizations of around $18.5 billion and $81 billion, respectively, are concentrating their efforts on funding the construction of 5G infrastructure internationally, which is also projected to affect the global market.

Future Market Insights, Inc., Thursday, February 2, 2023, Press release picture

Segmentation of FWA Subscription

By End-User:

Residential
Commercial
Industrial
Government

By Application:

Internet of Things (IoT)
Broadband Internet
Pay TV
Others

By Region:

North America
Latin America
Asia Pacif
Eastern Europe
Western Europe
Japan

Read the Full Report @ https://www.futuremarketinsights.com/reports/fwa-subscription

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Botulinum Toxin-Coated Microneedles Market Poised for Significant Growth, Projected to Reach USD 268.1 Million by 2033 at a 10.4% of CAGR

Global Botulinum Toxin-Coated Microneedles Industry — Global Botulinum Toxin-Coated Microneedles Market

The global botulinum toxin-coated microneedles market to reach a valuation of USD 109.6 million in 2024 and expand robustly to approximately USD 268.1 million by 2033. This substantial growth trajectory reflects a rising demand for minimally invasive aesthetic treatments, with botulinum toxin-coated microneedles emerging as an innovative solution within the cosmetic and dermatological sectors.

Factors Driving Market Expansion

The adoption of botulinum toxin-coated microneedles is being fueled by several key industry trends:

Growing Popularity of Minimally Invasive Aesthetic Procedures: These microneedles offer patients a less invasive alternative to traditional injectables, reducing downtime and enhancing comfort.
Technological Advancements in Cosmetic Dermatology: Ongoing research and development in microneedling technologies are leading to improved efficacy and safety, broadening the appeal of these procedures.
Rising Demand for Targeted Anti-Aging Solutions: As consumer interest in anti-aging products grows, botulinum toxin-coated microneedles provide targeted delivery of botulinum toxin, appealing to individuals seeking subtle, natural-looking results.

The report from Future Market Insights highlights a promising decade ahead for the botulinum toxin-coated microneedles market, underscoring strong growth potential as industry players innovate and refine product offerings to meet evolving consumer preferences.

Botulinum toxin-coated microneedles are a novel drug delivery system that has gained considerable attention in recent years. Botulinum toxin-coated microneedles offer a minimally invasive alternative to traditional injections for cosmetic procedures such as wrinkle reduction and facial rejuvenation.

As demand for minimally invasive procedures continues to grow, the market for botulinum toxin-coated microneedles is expected to expand. Moreover, with the rise of social media and the increasing visibility of celebrities and influencers, there has been a growing awareness of aesthetic procedures among the general public. This awareness is likely to drive demand for botulinum toxin-coated microneedles, as patients seek out less invasive and more effective options for cosmetic procedures.

Overall, the increasing demand for minimally invasive cosmetic procedures and growing awareness regarding aesthetic procedures will boost the market in the coming years

Competitive Landscape

Key players in the market are focused on increasing their pipeline portfolios and increasing the number of patents with respect to botulinum toxin-coated microneedles.

For instance:

On November 2021, Transderm Inc. (Allergan) applied for a patent application to the World Intellectual Property Organization (WIPO), Australia. These inventors have also applied for patents at various other WIPO offices; European Patent Office (EP3405247), Canada Patent Office (CA3011980), China Patent Office (CN109414575), US Patent Office (US20170209553) and also an international application (WO2017127840).
In 2019, JIANGSU YUEZHI BIO-MEDICINE CO., LTD. applied for a patent grant to the World Intellectual Property Organization (WIPO), China. The invention discloses a microneedle patch. The microneedle patch comprises a needle body and a substrate, wherein the needle body is prepared from the following raw materials in mass percent: 25-35% of arginine, 15-20% of beta-glucan, 26-35% of hydroxyethyl starch and 15-25% of recombinant collagen and the substrate is prepared from recombinant collagen.

A Full Report Overview

Key Companies Profiled

Transderm Inc. (Allergan); KYTHERA BIOPHARMACEUTICALS, INC. (Allergan); JIANGSU YUEZHI BIO-MEDICINE CO., LTD.

Key Segments Covered in Botulinum Toxin-coated Microneedles Industry Research

By Application:

Hyperhidrosis
Crow’s Feet

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Homeland Security Market to reach US$ 300 Billion by 2032; Cyber Security to be Most Prominent Area of Operations: Future Market Insights, Inc. Analysis

A recently published study by FMI expects the global homeland security market to augment at a 4.7% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 300 Billion is expected for the market. Homeland security refers to a system used to defend and protect a country from any anti-social threat.

It is a government endeavor to provide security and resilience against all potential natural and man-made calamities. Cloud-based security solutions are instantly becoming the most popular method of achieving IT security goals. Numerous enterprises, including IBM, HPE, Symantec, McAfee, and Cisco, provide cybersecurity solutions through a cloud-based Software-as-a-Service (SaaS) model.

These cloud-based solutions include a centralised way to safeguard online and mobile apps, as well as enterprise networks, all through the development, production, and implementation phases. The SaaS-based strategy is more straightforward and effective than the on-premises deployment strategy because it provides greater flexibility and scalability for solution deployments.

By 2032, the cybersecurity segment is expected to have the largest market share. Because of the growing threat of cybercrime, cyber terrorism, and internet fraud, cybersecurity is expected to have the highest revenue share in the overall homeland security market.

The widespread and increasing reliance on information and communication technology infrastructure has resulted in a focus on ensuring safety by combating cybercrime and advancing national defense capabilities.

Key Takeaways from the Market Study

FMI projects the global homeland security market to expand at a 4.7% value CAGR by 2032
The global homeland security market is estimated at a market value of US$ 189 Billion by 2022.
The global homeland security market is expected to garner a market value of US$ 300 Billion by 2032.
As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6% market share for homeland security in the assessment period 2022-2032.
As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 4% market share for homeland security in the assessment period 2022-2032.
As per Future Market Insights, the Europe is expected to grow at a CAGR of 3.7% market share for homeland security in the assessment period 2022-2032.
The public security is expected to grow at a CAGR of 4.3% in the forecast period 2022-2032.

“Growing investment by major players in the development of homeland security systems, as well as successful mergers and acquisitions amongst firms to provide more secure homeland security devices, are driving market expansion,” says an analyst at FMI.

Market Competition

Raytheon Technologies, IBM, L-3 Harris Technologies, Lockheed Martin Corporation and Northrop Grumman are some prominent homeland security manufacturers.

Recent Developments

In November 2022, Raytheon Intelligence & Space, a Raytheon Technologies division, today announced the opening of a new Registered Apprenticeship programme in McKinney, Texas, in collaboration with the US Department of Labour and Collin College.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global homeland security market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of End User (Public Security and Private Security) and by Security Type (Border Security, Mass Transit Security, Cyber Security, Critical Infrastructure Security, Aviation Security, Maritime Security, and Others), across five major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

To Get Sample Copy of Report Visit@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15856

About Future Market Insights (FMI)

Contact Us: